The regulatory role of alternative splicing in inflammatory bowel disease.

Zhou, Jianli; Zhang, Qiao; Zhao, Yuzhen; Song, Yuchen; Leng, Yanan; Chen, Moxian; Zhou, Shaoming; Wang, Zhaoxia

Zhou, Jianli; Zhang, Qiao; Zhao, Yuzhen; Song, Yuchen; Leng, Yanan; Chen, Moxian; Zhou, Shaoming; Wang, Zhaoxia.

Affiliation

Zhou J; Department of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Zhang Q; Department of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Zhao Y; Department of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Song Y; Co-Innovation Center for Sustainable Forestry in Southern China and Key Laboratory of National Forestry and Grassland Administration on Subtropical Forest Biodiversity Conservation, College of Biology and the Environment, Nanjing Forestry University, Nanjing, China.
Leng Y; Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Chen M; Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Zhou S; Clinical Laboratory, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Wang Z; Department of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.

Front Immunol ; 14: 1095267, 2023.

Article de En | MEDLINE | ID: mdl-37153612

Sujet(s)
Mots clés

Crohn's disease; alternative splicing; inflammatory bowel disease; splicing factor; splicing mutation; transcriptome; ulcerative colitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies inflammatoires intestinales / Rectocolite hémorragique / Maladie de Crohn Type d'étude: Diagnostic_studies Limites: Adult / Child / Humans Langue: En Journal: Front Immunol Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google